Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Advanced search

Results 1 - 10 of 24
Results/page:
12 3 > 
Nanomaterials via Gas-Phase Synthesis: A Design-Oriented Modelling and Engineering Approach
ID: 646121
Start date: 2015-09-15, End date: 2018-09-14
The main objective of the NanoDome project is to develop a robust model-based design and engineering toolkit for the detailed prediction of complex nanomaterial structures produced in a commercially-relevant generic bottom-up Gas-Phase (GP) synthesis process, to improve the...
Programme: H2020-EU.2.1.3.1.
Record Number: 196842
Last updated on: 2017-01-26
Periodic Reporting for period 1 - NanoDome (Nanomaterials via Gas-Phase Synthesis: A Design-Oriented Modelling and Engineering Approach)
The main objective of the NanoDome project is to develop a robust model-based design and engineering toolkit for the detailed prediction of complex nanomaterial structures produced in a commercially-relevant generic bottom-up Gas-Phase (GP) synthesis process, to improve the...
Programme: H2020-EU.2.1.3.1.
Record Number: 205010
Last updated on: 2017-11-10
BIOactive implantable CApsule for PANcreatic islets immunosuppression free therapy
ID: 646272
Start date: 2015-06-01, End date: 2019-05-31
The key therapeutic issue in diabetes mellitus type I and II is glycaemic control. Reductions of constant self-control, of insulin injections, and of long-term complications would have tremendous benefit for quality of life. The best therapy option is the transplantation of...
Programme: H2020-EU.2.1.3.1.
Record Number: 197087
Last updated on: 2017-06-23
Tailored Elastin-like Recombinamers as Advanced Systems for Cell Therapies in Diabetes Mellitus: a Synthetic Biology Approach towards a Bioeffective and Immunoisolated Biosimilar Islet/Cell Niche
ID: 646075
Start date: 2015-06-01, End date: 2019-05-31
ELASTISLET aims to create a breakthrough development in encapsulation technology and its use in cell and tissue therapies for the treatment of type 1 and 2 diabetes. ELASTISLET will combine leading technologies in biomaterial design, production and processing...
Programme: H2020-EU.2.1.3.1.
Record Number: 196840
Last updated on: 2017-07-12
Periodic Reporting for period 1 - ELASTISLET (Tailored Elastin-like Recombinamers as Advanced Systems for Cell Therapies in Diabetes Mellitus: a Synthetic Biology Approach towards a Bioeffective and Immunoisolated Biosimilar Islet/Cell Niche)
ELASTISLET is within the context of diabetes, a global epidemic that comprises a series of clinically and genetically heterogeneous physiological disorders. According to the first WHO Global report on diabetes demonstrates that the number of adults living with diabetes has...
Programme: H2020-EU.2.1.3.1.
Record Number: 198429
Last updated on: 2017-05-19
[PROGRAMME]
Record Number: 665021
[PROGRAMME]
Record Number: 665010
[PROGRAMME]
Record Number: 665020
Record Number: 665020
12 3 > 
List retrieved on: 2017-11-20
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top